Join
Live feed
·
PRReleasevia Quantisnow
CytoMed Therapeutics Limited logo

CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia

ByQuantisnow·Wall Street's wire, on your screen.
GDTC· CytoMed Therapeutics Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GDTC (CytoMed Therapeutics Limited) and more on Quantisnow.